BBIO vs QURE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 11, 2026

BBIO

50.2
AI Score
VS
BBIO Wins

QURE

39.4
AI Score

Investment Advisor Scores

BBIO

50score
Recommendation
HOLD

QURE

39score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BBIO QURE Winner
Revenue 438.19M 3.56M BBIO
Net Income -322.45M -53.53M QURE
Net Margin -73.6% -1502.9% BBIO
Operating Income -213.03M -45.72M QURE
ROE 12.8% -35.8% BBIO
ROA -26.5% -6.9% QURE
Total Assets 1.22B 778.71M BBIO
Cash 677.91M 139.99M BBIO
Debt/Equity -1.05 0.33 BBIO
Current Ratio 1.23 10.40 QURE
Free Cash Flow -268.89M -38.38M QURE

Relative Price Performance (Last 90 Days)

BBIO 1M: -1.7% · 3M: +16.0% QURE 1M: +22.7% · 3M: +95.4%

Current Technical Phase

BBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.9 · Price: $81.50

QURE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (20.8% over 20 days), RSI 64

RSI (14): 64.3 · Price: $48.37

Fundamentals Snapshot

Metric BBIO QURE
Market Cap
Forward P/E 532.0 -18.5
Trailing P/E
Revenue (TTM)
Revenue Growth 1.2% 0.1%
Gross Margin 0.9% -6.1%
Operating Margin -0.4% -8.7%
EPS -3.52 -4.06
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BBIO is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.